Xontogeny is a venture capital fund specializing in early-stage investment in health tech and biotech companies. Focused on Series A rounds, they provide financial support for developing new drugs and technologies targeting serious diseases. Xontogeny partners with entrepreneurs, offering leadership and operational expertise to help startups grow from inception to maturity. Their approach allows scientific founders to stay lean and retain more control and equity. One of their notable investments is Neurosterix.
